ArticleInternational journal of impotence research2026
The outcomes of inflatable penile prosthesis implantation in the context of Genital Gender Affirming Surgery in Assigned Female At Birth patients: A comparative study between cis-male Dacron modified and Zephyr Surgical Implants 475 Female To Male Penile Prosthesis.
Article in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Subsequent procedures after masculinizing surgery: neourethra and prosthetics].Urologie (Heidelberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ideal device to be implanted into a neophallus has yet to be identified. Since 2016 Zephyr Surgical Implant 475 Female To Male (ZSI 475 FtM, Switzerland) series penile prosthesis (PP) have been proposed as "ad hoc" device. The aim of the study is to compare the outcomes of cis-male Dacron modified PP with ZSI 475 FTM PP. A single-center prospective study was performed between March 2011 and April 2024. Patients received either the implantation of a cis-male Dacron modified PP or ZSI 475 FTM PP. The primary endpoint was the comparison of the surgical outcomes. The secondary endpoint was the evaluation of device survival. 47 assigned female at birth (AFAB) patients were included in: 29 underwent a cis-male Dacron modified PP, 18 received ZSI 475 FTM PP. The median follow-up was 36 months (IQR 13-70). A significantly shorter operative time was observed in ZSI FTM PP group when compared to cis-male Dacron modified PP group (mean value of 85 (IQR 78-97) VS. 105 (IQR 89-150) minutes, p 0.001). No statistically significant differences were found regarding the rate of postoperative complications, although the cis-male Dacron-modified PP appeared to have a higher tendency for infection (24.1% vs. 5.6%) and mechanical failure (31% vs. 22.2%, p = 0.09 and p = 0.51, respectively) compared with the ZSI 475 FTM PP. Explantation free survival (EFS) at 12 months was higher in the ZSI 475 FTM PP group (100 VS. 79.3%, p-value 0.039). However, at 24 months, this advantage was lost (94.4% VS. 72.4%, p value 0.062). Both cis-male Dacron modified and ZSI 475 FTM PP may guarantee satisfactory surgical outcomes. High powered prospective trials are warranted to confirm the data.
Indexed as
Identifiers
40696146What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.